Osteoporosis - Treatment and Complications

Citations 1-10 of 74 total displayed.

Most recent content (1 Oct 2011):

Commentaries
Antiresorptive Agents Differ in Their Mode of Action and Morphological Effects

Ego Seeman
IBMS BoneKEy 2011; 8: 433-437. [Full text] [PDF]  

Past content (since Jan 2001):

NEWS
Atypical Femoral Fractures: Perspective, Not Panic: Recent IBMS BoneKEy webinar examined clinical and radiological characteristics, epidemiology, pathogenetic mechanisms, risk factors, and clinical management

Neil Andrews
IBMS BoneKEy 2011; 8: 264-270. [Full text] [PDF]  

Perspectives
Anabolic Plus Antiresorptive: Is One Plus One More or Less Two?

Ego Seeman
IBMS BoneKEy 2011; 8: 221-228. [Abstract] [Full text] [PDF]  

Perspectives
Osteonecrosis of the Jaw: Recent Clinical and Preclinical Advances

Matthew R. Allen and Salvatore L. Ruggiero
IBMS BoneKEy 2011; 8: 141-153. [Abstract] [Full text] [PDF]  

Perspectives
The Promise and Dilemma of Cannabinoid Therapy: Lessons from Animal Studies of Bone Disease

Aymen I. Idris
IBMS BoneKEy 2011; 8: 84-95. [Abstract] [Full text] [PDF]  

Commentaries
Differential Effects of Strontium Ranelate, Bisphosphonates and Teriparatide on Bone Microstructure: Fact or Fiction?

Juliet E. Compston
IBMS BoneKEy 2010; 7: 414-417. [Full text] [PDF]  

Commentaries
Bisphosphonates for Breast Cancer Therapy and Prevention?

Rowan T. Chlebowski
IBMS BoneKEy 2010; 7: 364-368. [Full text] [PDF]  

NEWS
Atypical Subtrochanteric and Femoral Shaft Fractures in Bisphosphonate Users: Five Years and Counting, Yet Still Too Many Unanswered Questions

Neil A. Andrews
IBMS BoneKEy 2010; 7: 296-303. [Full text] [PDF]  

Commentaries
Vitamin D – Let's Get Back to the Evidence Base

Ian R. Reid
IBMS BoneKEy 2010; 7: 249-253. [Full text] [PDF]  

Perspectives
Nitrogen-Containing Bisphosphonates and Human T Cells

Ismahène Benzaid and Philippe Clézardin
IBMS BoneKEy 2010; 7: 208-217. [Abstract] [Full text] [PDF]  

[Next page] Pages: 1 2 3 4 5 6 7 8